These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 8299559

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Influence of cycloheximide on acute diabetogenic effects of S-carboxymethylated human growth hormone in obese (ob/ob) mice.
    Adamafio NA, Cameron CM, Kostyo JL.
    Horm Metab Res; 1988 Jul; 20(7):391-4. PubMed ID: 3049288
    [Abstract] [Full Text] [Related]

  • 4. Growth hormone inhibits activation of phosphatidylinositol phospholipase C by insulin in ob/ob mouse adipose tissue.
    Chou SY, Kostyo JL, Adamafio NA.
    Endocrinology; 1990 Jan; 126(1):62-6. PubMed ID: 2403523
    [Abstract] [Full Text] [Related]

  • 5. Acute effects of S-carboxymethylated human growth hormone on insulin resistance in the obese (ob/ob) mouse.
    Adamafio NA, Kostyo JL, Cameron CM, Trimark JR, Dunbar JC.
    Metabolism; 1988 Sep; 37(9):900-5. PubMed ID: 3047525
    [Abstract] [Full Text] [Related]

  • 6. The stimulatory effect of insulin on diacylglycerol generation in adipocyte membranes from ob/ob mice is impaired by growth hormone.
    Towns R, Kostyo JL, Martin D, Chou SY, Bennink MR.
    Endocrinology; 1993 Apr; 132(4):1671-6. PubMed ID: 8462467
    [Abstract] [Full Text] [Related]

  • 7. Reduced and S-carboxymethylated human growth hormone: a probe for diabetogenic action.
    Cameron CM, Kostyo JL, Rillema JA, Gennick SE.
    Am J Physiol; 1984 Nov; 247(5 Pt 1):E639-44. PubMed ID: 6496734
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Influence of age on responsiveness to diabetogenic action of growth hormone.
    Cameron CM, Kostyo JL.
    Diabetes; 1987 Jan; 36(1):88-92. PubMed ID: 3539676
    [Abstract] [Full Text] [Related]

  • 12. Growth hormone inhibits activation of phosphatidylinositol phospholipase C in adipose plasma membranes: evidence for a growth hormone-induced change in G protein function.
    Roupas P, Chou SY, Towns RJ, Kostyo JL.
    Proc Natl Acad Sci U S A; 1991 Mar 01; 88(5):1691-5. PubMed ID: 1848008
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Diabetogenic activity of native and biosynthetic human growth hormone in obese (ob/ob) mouse.
    Kostyo JL, Gennick SE, Sauder SE.
    Am J Physiol; 1984 Apr 01; 246(4 Pt 1):E356-60. PubMed ID: 6720889
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Ciglitazone, a new hypoglycemic agent. I. Studies in ob/ob and db/db mice, diabetic Chinese hamsters, and normal and streptozotocin-diabetic rats.
    Chang AY, Wyse BM, Gilchrist BJ, Peterson T, Diani AR.
    Diabetes; 1983 Sep 01; 32(9):830-8. PubMed ID: 6354790
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.